←Back to Expert Scholars
Translational Medicine / 转化医学Esophageal Squamous Cell Carcinoma Asia
Kei Muro
MD
🏢Aichi Cancer Center Hospital🌐Japan
Professor, Department of Clinical Oncology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kei Muro is a prominent Japanese GI oncologist who has contributed to CheckMate trials evaluating nivolumab-based regimens for ESCC. His clinical research addresses immunotherapy combination strategies for advanced esophageal squamous cell carcinoma. He is a leader in Japanese cooperative group GI cancer studies.
Share:
🧪Research Fields 研究领域
Esophageal squamous cell carcinoma
Nivolumab-ipilimumab
CheckMate trials
GI oncology
Japanese clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kei Muro 的研究动态
Follow Kei Muro's research updates
留下邮箱，当我们发布与 Kei Muro（Aichi Cancer Center Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment